ResearcherMoffitt Cancer CenterActive in the last 2 years
Benjamin Daniel Powers
Matched on ORCID iD 0000-0003-2679-6302; OpenAlex author ID A5082034852. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2019: 1 paper · 2020: 3 papers · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 11
- The impact of neighborhood socioeconomic deprivation on metastatic pancreatic cancer treatment and survival: An incidence-based, causally-structured observatio… Last author DOI 10.64898/2026.08.06.26359821↗
- Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of t… Co-author DOI 10.3389/fonc.2024.1362244↗
- The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with implications for surgical centralization. Co-author DOI 10.1016/j.sopen.2023.02.001↗
- A Path Forward for Understanding and Addressing Multifaceted Pancreatic Cancer Disparities. First author DOI 10.1053/j.gastro.2022.04.047↗
- Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort Study. Co-author DOI 10.1097/as9.0000000000000197↗
- The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis. Co-author DOI 10.1097/sla.0000000000003706↗
- The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pan… Co-author DOI 10.3390/cancers13040809↗
- Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A retrospective cohort analysis. Last author DOI 10.1002/jso.26103↗
- Completion of adjuvant therapy in patients with resected pancreatic cancer. Co-author DOI 10.1016/j.hpb.2019.07.008↗
- Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pa… Co-author DOI 10.1186/s12885-020-07182-9↗
- Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor … Co-author DOI 10.1002/cam4.2180↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jason B. Fleming · 8 shared papers, 2019–2026 · strength 1.10
- Paper The impact of neighborhood socioeconomic deprivation on metastatic pancreatic cancer treatment and survival: An inciden… DOI 10.64898/2026.08.06.26359821↗
- Paper The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with impl… DOI 10.1016/j.sopen.2023.02.001↗
- Paper Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A … DOI 10.1097/as9.0000000000000197↗
- Pamela Joy Hodul · 8 shared papers, 2019–2023 · strength 1.07
- Paper A Path Forward for Understanding and Addressing Multifaceted Pancreatic Cancer Disparities. DOI 10.1053/j.gastro.2022.04.047↗
- Paper The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with impl… DOI 10.1016/j.sopen.2023.02.001↗
- Paper Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A … DOI 10.1097/as9.0000000000000197↗
- Jennifer B. Permuth · 6 shared papers, 2019–2026 · strength 1.02
- Paper The impact of neighborhood socioeconomic deprivation on metastatic pancreatic cancer treatment and survival: An inciden… DOI 10.64898/2026.08.06.26359821↗
- Paper A Path Forward for Understanding and Addressing Multifaceted Pancreatic Cancer Disparities. DOI 10.1053/j.gastro.2022.04.047↗
- Paper The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with impl… DOI 10.1016/j.sopen.2023.02.001↗
- Mokenge Peter Malafa · 6 shared papers, 2020–2023 · strength 0.74
- Paper The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with impl… DOI 10.1016/j.sopen.2023.02.001↗
- Paper Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A … DOI 10.1097/as9.0000000000000197↗
- Paper Completion of adjuvant therapy in patients with resected pancreatic cancer. DOI 10.1016/j.hpb.2019.07.008↗
- Daniel A. Anaya · 4 shared papers, 2021–2026 · strength 0.69
- Paper The impact of neighborhood socioeconomic deprivation on metastatic pancreatic cancer treatment and survival: An inciden… DOI 10.64898/2026.08.06.26359821↗
- Paper The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with impl… DOI 10.1016/j.sopen.2023.02.001↗
- Paper Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A … DOI 10.1097/as9.0000000000000197↗
- José M. Pimiento · 5 shared papers, 2020–2023 · strength 0.62
- Paper The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with impl… DOI 10.1016/j.sopen.2023.02.001↗
- Paper Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A … DOI 10.1097/as9.0000000000000197↗
- Paper The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Cent… DOI 10.1097/sla.0000000000003706↗
- Jason W. Denbo · 3 shared papers, 2020–2023 · strength 0.40
- Paper The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with impl… DOI 10.1016/j.sopen.2023.02.001↗
- Paper Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A … DOI 10.1097/as9.0000000000000197↗
- Paper Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A … DOI 10.1002/jso.26103↗
- Joon Kyung Kim · 3 shared papers, 2020–2023 · strength 0.38
- Paper The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with impl… DOI 10.1016/j.sopen.2023.02.001↗
- Paper The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Cent… DOI 10.1097/sla.0000000000003706↗
- Paper Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A … DOI 10.1002/jso.26103↗
- Danielle K. DePeralta · 3 shared papers, 2020–2021 · strength 0.34
- Paper Completion of adjuvant therapy in patients with resected pancreatic cancer. DOI 10.1016/j.hpb.2019.07.008↗
- Paper The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Cent… DOI 10.1097/sla.0000000000003706↗
- Paper Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A … DOI 10.1002/jso.26103↗
- Apurva Raghu · 1 shared paper, 2026 · strength 0.29
- Kelvin Allenson · 1 shared paper, 2023 · strength 0.16
- Dae Won Kim · 1 shared paper, 2023 · strength 0.16
- Dae Won Kim · 1 shared paper, 2022 · strength 0.13
- Luke Daniel Rothermel · 1 shared paper, 2021 · strength 0.11
- Gilbert Zvikomborero Murimwa · 1 shared paper, 2020 · strength 0.11
- David Roife · 1 shared paper, 2020 · strength 0.11
- David T. Pointer · 1 shared paper, 2020 · strength 0.11
- Daniel K. Jeong · 1 shared paper, 2019 · strength 0.07
- Andrew R. Judge · 1 shared paper, 2019 · strength 0.07
- Dung‐Tsa Chen · 1 shared paper, 2019 · strength 0.07
- Miles E. Cameron · 1 shared paper, 2019 · strength 0.07
- Jose Trevino · 1 shared paper, 2019 · strength 0.07
- Nipun B. Merchant · 1 shared paper, 2019 · strength 0.07
- Thomas J. George · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.